NCT06162663 2026-02-27
Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors
Medical University of South Carolina
Phase 4 Terminated
Medical University of South Carolina
Ottawa Hospital Research Institute
University of California, San Francisco
Georgetown University
Palleos Healthcare GmbH
Eli Lilly and Company
Seoul National University Hospital
University Hospital, Antwerp
HealthPartners Institute
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Novartis
SenoRx, Inc.
Novartis
Novartis